Literature DB >> 21857054

Review article: bone defect classifications in revision total knee arthroplasty.

Yi Yan Qiu1, Chun Hoi Yan, Kwong Yuen Chiu, Fu Yuen Ng.   

Abstract

There are several classification systems for bone defects in revision total knee arthroplasty. Each has its own drawbacks, and none satisfies all the clinical demands. Therefore, a new classification system and treatment guideline based on a combination of criteria (location, side, containment, and severity of the bone defect) is necessary.

Entities:  

Mesh：

Year:  2011        PMID： 21857054     DOI： 10.1177/230949901101900223

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN： 1022-5536            Impact factor:   1.118


  5 in total

Review 1.  Outcomes of Primary Total Knee Arthroplasty in Fractures Around the Knee in the Elderly: A Systematic Review and Pooled Analysis of 212 Patients Across 11 Studies.

Authors:  Parth Bansal; Prasoon Kumar; Karan Jindal; Vishal Kumar; Sameer Aggarwal; Mandeep S Dhillon
Journal:  Indian J Orthop       Date:  2021-12-01       Impact factor: 1.251

2.  CORR Insights®: What is the Reliability of a New Classification for Bone Defects in Revision TKA Based on Preoperative Radiographs?

Authors:  Charles N Cornell
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

3.  Correlation of tibial bone defect shape with patient demographics following total knee revision.

Authors:  Madhav Bole; Matthew Teeter; Brent A Lanting; James L Howard
Journal:  J Orthop       Date:  2018-03-27

Review 4.  The Great Need of a Biomechanical-Based Approach for Surgical Methods of Giant Cell Tumor: A Critical Review.

Authors:  Azadeh Ghouchani; Gholamreza Rouhi
Journal:  J Med Biol Eng       Date:  2017-06-22       Impact factor: 1.553

5.  Short-term results of the management of severe bone defects in primary TKA with cement and K-wires.

Authors:  Muhammet Sadik Bilgen; Gokay Eken; Nejat Guney
Journal:  Acta Orthop Traumatol Turc       Date:  2017-07-30       Impact factor: 1.511
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.